Renal replacement therapy in sepsis-induced acute renal failure

Show simple item record

dc.contributor.author Rajapakse, S.
dc.contributor.author Rodrigo, C.
dc.contributor.author Rajapakse, A.
dc.contributor.author Kirthinanda, D.
dc.contributor.author Wijeratne, S.
dc.date.accessioned 2011-11-21T10:58:02Z
dc.date.available 2011-11-21T10:58:02Z
dc.date.issued 2009
dc.identifier.citation Saudi J Kidney Dis Transpl. 2009 Jul;20(4):553-9 en_US
dc.identifier.uri http://archive.cmb.ac.lk:8080/xmlui/handle/70130/457
dc.description.abstract Acute renal failure (ARF) is a common complication of sepsis and carries a high mortality. Renal replacement therapy (RRT) during the acute stage is the mainstay of therapy. Va-rious modalities of RRT are available. Continuous RRT using convective methods are preferred in sepsis-induced ARF, especially in hemodynamically unstable patients, although clear evidence of benefit over intermittent hemodialysis is still not available. Peritoneal dialysis is clearly inferior, and is not recommended. Early initiation of RRT is probably advantageous, although the optimal timing of dialysis is yet unknown. Higher doses of RRT are more likely to be beneficial. Use of bio-compatible membranes and bicarbonate buffer in the dialysate are preferred. Anticoagulation during dialysis must be carefully adjusted and monitored. en_US
dc.language.iso en en_US
dc.title Renal replacement therapy in sepsis-induced acute renal failure en_US
dc.type Journal abstract en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account